ProjectAddendum No 01 zu einer interventionellen Studie
Basic data
Title:
Addendum No 01 zu einer interventionellen Studie
Duration:
01/11/2014 to 31/10/2020
Abstract / short description:
A phase 3, multicenter, randomized, double-blind, placebo and active comparator-controlled study evaluating the efficacy and safety of Guselkumab with randomized withdrawal and retreatment
Keywords:
dermatology
Dermatologie
clinical trial
klinische Studie
psoriasis therapeutics
Psoriasis Therapeutika
psoriasis
Schuppenflechte
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Neuss, Nordrhein-Westfalen, Germany